Joel A Sincavage

Array ( [id] => 151843 [patent_doc_number] => 07678775 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-16 [patent_title] => 'ILK inhibitors for the treatment of renal disease' [patent_app_type] => utility [patent_app_number] => 11/855884 [patent_app_country] => US [patent_app_date] => 2007-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6533 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/678/07678775.pdf [firstpage_image] =>[orig_patent_app_number] => 11855884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9831870 [patent_doc_number] => 08940683 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-27 [patent_title] => 'Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors' [patent_app_type] => utility [patent_app_number] => 12/377027 [patent_app_country] => US [patent_app_date] => 2007-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33852 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12377027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5337895 [patent_doc_number] => 20090054359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'COMPOSITIONS AND THEIR USES DIRECTED TO DIACYLGLYCEROL ACYLTRANSFERASE 1' [patent_app_type] => utility [patent_app_number] => 11/834640 [patent_app_country] => US [patent_app_date] => 2007-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15341 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054359.pdf [firstpage_image] =>[orig_patent_app_number] => 11834640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4944469 [patent_doc_number] => 20080081795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-03 [patent_title] => 'Suppression of nuclear factor-kappaB dependent processes using oligonucleotides' [patent_app_type] => utility [patent_app_number] => 11/888342 [patent_app_country] => US [patent_app_date] => 2007-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8338 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20080081795.pdf [firstpage_image] =>[orig_patent_app_number] => 11888342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792621 [patent_doc_number] => 20080293595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'siRNA targeting protein tyrosine phosphatase-1B (PTP1B)' [patent_app_type] => utility [patent_app_number] => 11/880755 [patent_app_country] => US [patent_app_date] => 2007-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 34804 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293595.pdf [firstpage_image] =>[orig_patent_app_number] => 11880755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5291177 [patent_doc_number] => 20090023907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'siRNA targeting kinesin spindle protein (KSP)' [patent_app_type] => utility [patent_app_number] => 11/880623 [patent_app_country] => US [patent_app_date] => 2007-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 34890 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023907.pdf [firstpage_image] =>[orig_patent_app_number] => 11880623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6223304 [patent_doc_number] => 20100056607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'COMPOSITIONS AND THEIR USES DIRECTED TO HBXIP' [patent_app_type] => utility [patent_app_number] => 12/374635 [patent_app_country] => US [patent_app_date] => 2007-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22666 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056607.pdf [firstpage_image] =>[orig_patent_app_number] => 12374635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5290486 [patent_doc_number] => 20090023216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Double-Stranded Oligonucleotides' [patent_app_type] => utility [patent_app_number] => 11/776313 [patent_app_country] => US [patent_app_date] => 2007-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 43175 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023216.pdf [firstpage_image] =>[orig_patent_app_number] => 11776313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6581799 [patent_doc_number] => 20100129870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'METHOD FOR OBTAINING OLIGONUCLEOTIDE' [patent_app_type] => utility [patent_app_number] => 12/376182 [patent_app_country] => US [patent_app_date] => 2007-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6900 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129870.pdf [firstpage_image] =>[orig_patent_app_number] => 12376182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6530174 [patent_doc_number] => 20100015232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'NANOPARTICLES FOR NUCLEIC ACID DELIVERY' [patent_app_type] => utility [patent_app_number] => 12/307566 [patent_app_country] => US [patent_app_date] => 2007-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10254 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015232.pdf [firstpage_image] =>[orig_patent_app_number] => 12307566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4733393 [patent_doc_number] => 20080050372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'INHIBITION OF ALPHA-2 HS GLYCOPROTEIN (AHSG/FETUIN) IN OBESITY AND INSULIN CONTROL OF GLUCOSE HOMEOSTASIS' [patent_app_type] => utility [patent_app_number] => 11/773883 [patent_app_country] => US [patent_app_date] => 2007-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23023 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20080050372.pdf [firstpage_image] =>[orig_patent_app_number] => 11773883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7751679 [patent_doc_number] => 08110557 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-07 [patent_title] => 'Gamma secretase inhibitor for treatment of herpesvirus infection' [patent_app_type] => utility [patent_app_number] => 11/822419 [patent_app_country] => US [patent_app_date] => 2007-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 18 [patent_no_of_words] => 18193 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/110/08110557.pdf [firstpage_image] =>[orig_patent_app_number] => 11822419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5046764 [patent_doc_number] => 20070265438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'siRNA targeting polo-like kinase-1 (PLK-1)' [patent_app_type] => utility [patent_app_number] => 11/818936 [patent_app_country] => US [patent_app_date] => 2007-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 34486 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20070265438.pdf [firstpage_image] =>[orig_patent_app_number] => 11818936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 83677 [patent_doc_number] => 07741304 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Casein kinase 2 antisense therapy' [patent_app_type] => utility [patent_app_number] => 11/763366 [patent_app_country] => US [patent_app_date] => 2007-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13709 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741304.pdf [firstpage_image] =>[orig_patent_app_number] => 11763366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4879271 [patent_doc_number] => 20080152654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESIS' [patent_app_type] => utility [patent_app_number] => 11/761940 [patent_app_country] => US [patent_app_date] => 2007-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20757 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20080152654.pdf [firstpage_image] =>[orig_patent_app_number] => 11761940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4629386 [patent_doc_number] => 08008272 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => 'Nuclease-resistant RNA aptamer inhibiting replication of hepatitis C virus replicon' [patent_app_type] => utility [patent_app_number] => 12/516311 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8185 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/008/08008272.pdf [firstpage_image] =>[orig_patent_app_number] => 12516311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8713283 [patent_doc_number] => 08399424 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-19 [patent_title] => 'Method for controlling the amount of gene product, and agent for controlling the amount of gene product' [patent_app_type] => utility [patent_app_number] => 12/303908 [patent_app_country] => US [patent_app_date] => 2007-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 15 [patent_no_of_words] => 11170 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12303908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8232635 [patent_doc_number] => 08198078 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-12 [patent_title] => 'Fucosyl transferase gene' [patent_app_type] => utility [patent_app_number] => 11/808097 [patent_app_country] => US [patent_app_date] => 2007-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 23 [patent_no_of_words] => 11312 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/198/08198078.pdf [firstpage_image] =>[orig_patent_app_number] => 11808097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5392312 [patent_doc_number] => 20090209625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'MODULATION OF CHREBP EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/301460 [patent_app_country] => US [patent_app_date] => 2007-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28902 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209625.pdf [firstpage_image] =>[orig_patent_app_number] => 12301460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4658157 [patent_doc_number] => 20080027019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'OLIGONUCLEOTIDE COMPOSITIONS AND METHODS FOR THE MODULATION OF THE EXPRESSION OF B7 PROTEIN' [patent_app_type] => utility [patent_app_number] => 11/748422 [patent_app_country] => US [patent_app_date] => 2007-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 46889 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20080027019.pdf [firstpage_image] =>[orig_patent_app_number] => 11748422 [rel_patent_id] =>[rel_patent_doc_number] =>)